Metraipolis › archive › dc_27eedc1393fa

Hepatitis C Eradication Improves Oncologic and Clinical Outcomes in Patients Treated With Atezolizumab Plus Bevacizumab — Europe PMC PMID:40980951

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40980951
DOI: 10.1111/liv.70362
License (as archived): solo-consultazione
Archived: 2026-11-09T15:43:48.050Z
SHA-256 of the archived text: e60c7f4f1dcddf431a4ca19f41afbf0b03ebaf29e3ce43c587c8c98daeec205f
Stable URL of this page: https://metraipolis.com/documento/dc_27eedc1393fa

How to cite

Hepatitis C Eradication Improves Oncologic and Clinical Outcomes in Patients Treated With Atezolizumab Plus Bevacizumab — Europe PMC PMID:40980951 — Europe PMC (en), https://europepmc.org/article/MED/40980951 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_27eedc1393fa (Metraipolis archive dc_27eedc1393fa, sha256 e60c7f4f1dcddf431a4ca19f41afbf0b03ebaf29e3ce43c587c8c98daeec205f)

BibTeX

@misc{dc27eedc1393fa,
  title = {Hepatitis C Eradication Improves Oncologic and Clinical Outcomes in Patients Treated With Atezolizumab Plus Bevacizumab — Europe PMC PMID:40980951},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40980951},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_27eedc1393fa; sha256 e60c7f4f1dcddf431a4ca19f41afbf0b03ebaf29e3ce43c587c8c98daeec205f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40980951. Agents can read the archived copy with the MCP tool read_document.